1. Home
  2. Live Updates
  3. Blueprint medicines corp

Page 2 - Blueprint Medicines Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Blueprint medicines corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Blueprint Medicines Corp Today - Breaking & Trending Today

Rigel Pharma Acquires US Rights To Gavreto From Blueprint Medicines; Stock Up In Pre-Market

(RTTNews) - Rigel Pharmaceuticals, Inc. (RIGL), Thursday announced that it has agreed to acquire the U.S. rights to Gavreto from Blueprint Medicin. ....

Blueprint Medicines Corp , Rigel Pharmaceuticals Inc , Blueprint Medicines ,

Rigel Pharma Acquires US Rights To Gavreto From Blueprint Medicines; Stock Up In Pre-Market

Rigel Pharmaceuticals, Inc. (RIGL), Thursday announced that it has agreed to acquire the U.S. rights to Gavreto from Blueprint Medicines Corp. for an initial payment of $10 million, followed by an additional $5 million after one year of the closing date. ....

Rigel Pharmaceuticals Inc , Blueprint Medicines Corp , Rigel Pharmaceuticals , Blueprint Medicines ,

Rigel takes on US marketing of Blueprint's Gavreto

Blueprint Medicines Corp. found a new U.S. commercialization home for Gavreto (pralsetinib) through an agreement with Rigel Pharmaceuticals Inc. potentially worth $117.5 million, now that Roche Holding AG has relinquished all rights. ....

Blueprint Medicines Corp , Roche Holding , Rigel Pharmaceuticals Inc , Blueprint Medicines , Rigel Pharmaceuticals , Blueprint Medicines Corp , Rigel Pharmaceuticals Inc , Roche Holding Ag , Non Small Cell Lung Cancer , Deals Andm Amp A , Ret Inhibitor , Medullary Thyroid Cancer ,

Blueprint Medicines: Q4 Earnings Snapshot -February 15, 2024 at 07:27 am EST

CAMBRIDGE, Mass. CAMBRIDGE, Mass. Blueprint Medicines Corp. on Thursday reported a loss of $110.9 million in its fourth quarter.
The Cambridge, Massachusetts-based company said it had. ....

United Kingdom , United States , Blueprint Medicines Corp , Zacks Investment Research , Investment Research , Automated Insights ,

USD 1.02 billion growth in Gastrointestinal Stromal Tumors Therapeutics (GIST) Market, Increasing awareness campaigns about GIST boosting the growth, 17000 + Technavio

/PRNewswire/ The gastrointestinal stromal tumors therapeutics market is anticipated to grow by USD 1.02 billion, progressing at a CAGR of 6.01% during the. ....

United States , United Kingdom , Prnewswire Thegastrointestinal , Ipsen Pharma , Jesse Maida , Ascentage Pharma , Company Landscape , Company Analysis , Theseus Pharmaceuticals , Sun Pharmaceutical Industries Ltd , Merck Kgaa , Merck Kga , Xencor Inc , Life Raft Group , Bayer Ag , Daiichi Sankyo Co , Technavio Research , Deciphera Pharmaceuticals Inc , Takeda Pharmaceutical Co , Blueprint Medicines Corp , Pfizer Inc , Bristol Myers Squibb Co , Bristol Myers Squibb , Daiichi Sankyo , Takeda Pharmaceutical , Distribution Channel ,